MARLBOROUGH, Mass.--(BUSINESS WIRE)--Cytyc Corporation (Nasdaq: CYTC), a leading provider of surgical and diagnostic products targeting women’s health and cancer diagnostics, today announced that a new, independent Australian study evaluating the ThinPrep Imaging System is featured in a recent issue of the British Medical Journal (BMJ). The July 7, 2007 edition of the BMJ, titled “Advantages of Liquid Based Cytology,” also includes a commentary describing the ThinPrep Imaging System and an editorial confirming the advantages of this technology.